Introduction {#s1}
============

The midline of the central nervous system arises as a result of complex morphogenetic and inductive interactions. In the spinal cord, the roof plate is formed dorsally by the fusion of the 2 lateral margins of the neural plate, whereas the floor plate is induced ventrally by signals from the underlying notochord. The roof plate and the floor plate, in turn, function as secondary organizers, to regulate dorso-ventral identity along the entire length of the spinal cord ([@BHS421C65]; [@BHS421C7]; [@BHS421C31]). In the forebrain, the dorsal midline is more complicated as a result of the prosencephalic vesicle giving rise to paired telencephalic evaginations and a central diencephalic vesicle. The choroid plexus has a central position in the forebrain: It forms at the medial edges of the telencephalic neuroepithelium (the telencephalic choroid plexus) and also at the roof of the diencephalon. An additional site of choroid plexus formation is the roof of the hindbrain. In this study, we examine 3 key forebrain structures connected with the telencephalic choroid plexus.

The telencephalic choroid plexus is flanked rostrally by the septum, on its telencephalic side by the cortical hem, and on its diencephalic side by the thalamic eminence.

Though the septum, hem, and thalamic eminence have been studied in literature as independent structures, they have certain fundamental similarities with respect to anatomy and function. Anatomically, these 3 structures surround the telencephalic choroid plexus, being physically connected with it (Figs [1](#BHS421F1){ref-type="fig"} and [2](#BHS421F2){ref-type="fig"}). They are each positioned at strategic boundaries in the forebrain and have known or suggested roles as secondary organizers. Finally, each of these structures produce Cajal--Retzius cells, which are the sources of Reelin that is necessary for cortical development ([@BHS421C16]; [@BHS421C42]). Figure 1.Medial forebrain structures. (*A*--*C*) Schematics of 3 coronal levels of sectioning in the E12.5 mouse brain, corresponding to "i," "ii," and "iii" in N, respectively. "i" is at the level of septum (yellow); "ii" and "iii" show the cortical hem (red) and the thalamic eminence (TE; blue). TE is contiguous with the CGE as seen in level "iii." (*D*) Schematic depicting the positions of septum, cortical hem, and TE in a horizontal section, corresponding to "iv" in N. The 3 rostro-caudal coronal levels (i, ii, and iii) and 1 horizontal level (iv) of sectioning in the E12.5 whole forebrain are schematized in N. (*E*) Dorsal view of a 3-D model of E12.5 brain showing the locations of septum (yellow), hem (red), and TE (blue), encircling the choroid plexus (green). *Wnt8b* is expressed in the medial neuroepithelium of the dorsal telencephalon, including the pallial septum (*F*), cortical hem (open arrowhead), and also in the ventricular zone of TE (asterisk; *G*--*I*). (*J*--*M*) *Zic2* is expressed in the entire medial forebrain, including the forebrain hem system. CGE, caudal ganglionic eminence; h, hem; s, septum; TE, thalamic eminence. Scale bar: 300 µm. Figure 2.Connection of the choroid plexus with components of the forebrain hem system. (*A*) Schematic of the medial view of an E11.5 hemi-forebrain showing the position of the forebrain hem system (yellow), encircling the choroid plexus (cp; green). The dashed line (*A* and *C*) corresponds to the diencephalic midline that was bisected for the hemi-forebrain preparation (*B*). Whole mount in situ hybridization of an E12.5 hemi-forebrain reveals *Wnt2b* expression, specific to the cortical hem (purple), and *AP2α* expression, specific to the thalamic eminence (asterisk; brown). (*C*) *Lhx1* is expressed in the E11.5 septum and thalamic eminence (asterisk) and also weakly in the cortical hem. (*D*) Lateral view of a single hemisphere in 3-D model of E12.5 brain showing the location of the septum (yellow), hem (red), and thalamic eminence (blue), encircling the choroid plexus (green). (*E*) E12.5 mouse brain sections processed for marker *Ttr* show the presence of the choroid plexus adjacent to both the lateral ventricles and the third ventricle. (*F*--*H*) Human sections immunostained by calbindin antibody show the development of choroid plexus from 7 to 10/11 GWs. (*H*) An oblique section of 10/11-GW human brain that shows the connection of choroid plexus with both the septum and cortical hem (open arrowheads), as also depicted in *I*. cp, choroid plexus; h, hem; s, septum; TE, thalamic eminence; III V, third ventricle. Scale bar: 200 µm (*B* and *C*).

The cortical hem is a Wnt and bone morphogenetic protein (Bmp) rich signaling centre that is connected to the choroid plexus on one side and the cortical neuroepithelium on the other ([@BHS421C23]). The hem was recently found to act as a secondary organizer that induces the formation of the hippocampus in the adjacent cortical neuroepithelium ([@BHS421C33]), drawing a remarkable parallel with the roof plate of the spinal cord. At the rostral end of the telencephalon, the cortical hem is contiguous with another midline structure, the septum, a site that is enriched in Fgf family signaling molecules ([@BHS421C24]) and known to function as an organizer for cortical areal patterning ([@BHS421C20]). The thalamic eminence is a transient medial structure at the diencephalic--telencephalic boundary (DTB) of the forebrain. Based on its position and expression of signaling molecules, the thalamic eminence has been hypothesized to also serve as an organizer or a putative signaling centre ([@BHS421C1]; [@BHS421C29]; [@BHS421C18]). Though the septum continues into maturity, the hem and thalamic eminence are not discernible by late embryonic life: The hem gives way to the fimbria, while the thalamic eminence gets subsumed in diencephalic derivatives ([@BHS421C23]; [@BHS421C1]).

A distinctive feature of the septum, hem, and thalamic eminence is that they each produce a unique population of Cajal--Retzius cells, which are among the earliest born neurons of the developing forebrain ([@BHS421C37]; [@BHS421C55]; [@BHS421C6]; [@BHS421C67]; [@BHS421C14]; [@BHS421C2]; [@BHS421C9]; [@BHS421C59]; [@BHS421C35]). Though the Cajal--Retzius cells arising from these different origins are molecularly distinct, all secrete Reelin, a glycoprotein known to be critical for cortical lamination ([@BHS421C16]; [@BHS421C42]). The expression of Reelin has been examined in extant vertebrates and appears to have been amplified in mammals, consistent with a role in the evolution of migratory mechanisms that led to the formation of laminated neocortex ([@BHS421C5]; [@BHS421C58]). In the developing human brain, which has a protracted migratory period, Cajal--Retzius cells display complex morphologies and extend a distinctive Reelin-positive axonal plexus at the interface of both the marginal zone and the cortical plate ([@BHS421C36]). Furthermore, human Cajal--Retzius cells specifically express the Human accelerated region gene, HARF1, indicating human-specific traits of this cell type, further supporting an important role for these cells in neocortical evolution ([@BHS421C46]). Finally, experiments using the combinations of transgenic and knockout mice have suggested that Cajal--Retzius cells may act as "mobile patterning units" providing regionalization cues to the developing telencephalon ([@BHS421C22]). The septum, hem, and thalamic eminence, being the sites of the origin of Cajal--Retzius cells, are therefore important not only from a developmental, but also an evolutionary perspective.

In earlier work, we showed that the cortical hem expands in the absence of LIM-homeodomain transcription factor Lhx2 ([@BHS421C11]; [@BHS421C33]). Here, we show that loss of Lhx2 also results in the expansion of septum and thalamic eminence. Concomitantly, there is a dramatic overproduction of Cajal--Retzius cells in the *Lhx2* mutant. Thus Lhx2, a critical regulator of early forebrain development, controls the extent of the septum, hem, and thalamic eminence, and as a consequence, also the number of Cajal--Retzius cells produced. Since these 3 midline structures are developmentally and functionally linked, we propose that they together form a "forebrain hem system" that serves as a multicomponent patterning and organizing center for the medial forebrain.

Defective formation of the forebrain midline can give rise to severe malformations such as holoprosencephaly, one of the most common defects in brain development. Here, we compare these structures in the embryonic mouse and human forebrain. Our interpretation of the septum, hem, and thalamic eminence as a unified forebrain hem system offers a new framework in which such defects may be interpreted, leading to a better understanding of midline pathologies.

Materials and Methods {#s2}
=====================

Animals and Sample Preparation {#s2a}
------------------------------

### Mice {#s2a1}

All procedures followed Institute Animal Ethics Committee guidelines and National Institutes of Health guidelines for the care and use of animals (mice). Timed pregnant *Lhx2*+/− mice (gift of F.D. Porter, NIH) were used. Pregnant dams were obtained from the Tata Institute animal breeding facility. A tamoxifen-inducible *CreER* line (strain name: B6; 129-*Gt(ROSA)26Sor^tm1(cre/ERT)Nat^*/J; stock number: 004847) was obtained from the Jackson Laboratory. The floxed *Lhx2* line (*Lhx2lox/lox)* was obtained from E.S. Monuki\'s lab. For in situ hybridization, the mouse embryos were harvested in phosphate buffer saline at E11, E11.5, and E12.5, fixed in 4% paraformaldehyde (PFA), equilibrated in 30% sucrose made in 4% PFA, and sectioned at 30 μm on a freezing microtome.

### Human {#s2a2}

Seven human embryonic and fetal brains (from 6 to 10/11 gestational weeks, GW) were examined. Embryonic brains were obtained and staged after legal abortions, following national guidelines in Spain and Belgium and in accordance with the institutional medical ethics committee guidelines ([@BHS421C38]). Fetal brains were obtained after spontaneous abortions, under the same ethical guidelines. The whole heads were fixed immediately upon collection, in Bouin\'s fixative, embedded in paraffin, and cut in series of 10 μm sections. They were immunostained with antibodies to calbindin and Tbr1, as well as other antibodies, as described in [@BHS421C38] and re-examined for the present study.

### Histochemical Procedures {#s2a3}

In situ hybridization was performed as described previously in [@BHS421C12]. Briefly, the hybridization was performed overnight at 70°C in 4× sodium chloride-sodium citrate-citric acid buffer (SSC), 50% formamide, and 10% sodium dodecyl sulphate. Post hybridization washes were at 70°C in 2× SSC and 50% formamide. These were followed by washes in 2× SSC, 0.2× SSC, and then Tris-buffered saline with 1% Tween-20 (TBST). Anti-digoxigenin Fab fragments (Roche) were used at 1:5000 in TBST, and the color reaction using 4-nitro blue tetrazolium chloride + 5-bromo-4-chloro-3-indolyl phosphate (Roche) was performed according to the manufacturer\'s instructions. Immunohistochemistry were performed as described in [@BHS421C53]. Primary antibodies used are mouse anti-5-bromo-2′deoxyuridine (anti-BrdU; Roche; 1:100) and rabbit polyclonal anti-Ki67 (Abcam; 1:50). Immunohistochemistry on human embryonic and fetal sections was performed as described in [@BHS421C38] using a rabbit polyclonal calbindin antibody (Swant, Bellinzona, Switzerland) and Tbr1 antibody (kind gift from R. Hevner).

### Quantitative Analysis {#s2a4}

For area measurement studies, data were collected from 3 contiguous sections taken from 3 mouse brains at E12.5. The area was calculated using ImageJ software (NIH). For labeling index and quit fraction studies, confocal microscopy was used. Individual cells in the sections were imaged at a magnification of 40× using Zeiss LSM 510 Meta. Image stacks were generated by scanning at intervals of 0.44 μm using filters of the appropriate wavelengths. The cells were quantified using ImageJ software. The proliferating pool of cells in the telencephalon is known to include not only neuroepithelial stem cells, but also microglia and endothelial cells. However, the microglia have only just begun to invade the cortex at E10.5--E11.5 ([@BHS421C54]). Consistent with the description of microglial morphology ([@BHS421C28]), cells with compact 4′,6-diamidino-2-phenylindole (DAPI)-positive nuclei surrounded by DAPI-negative cytoplasm were found in our sections, mostly near the pial surface. Neural progenitors in contrast had large DAPI-positive nuclei that occupied most of the volume of the cell. Endothelial cells enter the cortex from capillaries, and at the early stages we examined would be expected to be in close association with them. We did not use regions with capillaries in our counts. Even though both microglia and endothelial cells peak in number only later, it is possible that our cell counts included some cells other than neuroepithelial cells. Sections from 3 brains were scored. For each brain, 600--1000 cells were counted for the labeling index and 500--700 cells for the quit fraction. Statistical analysis was done using a 2-tailed Student\'s *t*-test in Microsoft Excel.

### 3-D Modeling and Video {#s2a5}

The 3-dimensional (3-D) model of the forebrain hem system was developed by using the software BioViz3D version 3.0. 42 serial sections (25 µm each) of an E12.5 wild-type brain were imaged and arranged in the rostrocaudal order. Contours were drawn in each section, based on morphology for the choroid plexus, and based on the expression of specific markers for the cortical hem, septum, and thalamic eminence. The 3-D reconstruction was created using these contours for the entire stack. The movie was made using the movie maker software Hypercam2.

Results {#s3}
=======

The Morphological Relationships of Medial Forebrain Structures {#s3a}
--------------------------------------------------------------

The septum, hem, and thalamic eminence share the expression of several transcription factors and signaling molecules. In E12.5 coronal sections, the septum appears at rostral levels, whereas the hem and thalamic eminence appear at mid and caudal levels. In rostral sections, *Wnt8b* expression is seen in the medial telencephalon extending into the pallial septum, but excludes the subpallial septum (Fig. [1](#BHS421F1){ref-type="fig"}*F*). *Wnt8b* is also expressed in the thalamic eminence and hem (Fig. [1](#BHS421F1){ref-type="fig"}*G*,*H*). At caudal levels, the thalamic eminence is contiguous with the caudal ganglionic eminence (CGE) in the telencephalon (Fig. [1](#BHS421F1){ref-type="fig"}*C*,*H*,*L*). Horizontal sections at E12.5 are useful to examine all 3 structures simultaneously. In such sections, *Wnt8b* expression on either side of the choroid plexus suggests that the thalamic eminence may be considered to be a "diencephalic hem," a counterpart to the telencephalic cortical hem (Fig. [1](#BHS421F1){ref-type="fig"}*I*). The expression of transcription factor *Zic2* is seen in a broad region of the medial forebrain, including the septum, hem, and thalamic eminence (Fig. [1](#BHS421F1){ref-type="fig"}*J*--*M*; [@BHS421C43]). *Zic2* is a major candidate gene implicated in holoprosencephaly, and alterations in Zic2 function may affect the entire forebrain hem system.

A rostrocaudal series of E12.5 coronal sections were collated into a 3-D model, and animated into a movie (M1; still images in Figs [1](#BHS421F1){ref-type="fig"}*E* and [2](#BHS421F2){ref-type="fig"}*D*) that begins with the choroid plexus and illustrates how the septum, hem, and thalamic eminence collectively encircle it. These 3 structures at key forebrain boundaries mark the transition from the telencephalic choroid plexus to the rest of the forebrain: The septum and hem connecting the choroid plexus to the telencephalon, and the thalamic eminence connecting it to the diencephalon.

To examine the forebrain system in intact preparations, we prepared whole-mount "hemi forebrains" at E11.5--E12.5, by making a cut along the diencephalic midline, such that each telencephalic hemisphere remains attached to a hemi-diencephalon. In such preparations, in situ hybridization reveals *Wnt2b* expression in the cortical hem, and *AP2α* in the thalamic eminence; *Lhx1* expression labels both these structures and the septum (Fig. [2](#BHS421F2){ref-type="fig"}*B*,*C*).

The relative position of these structures is revealed in the sections of human embryonic and early fetal brains, with an E12.5 mouse section alongside for comparison, in which the overall stage of development appears similar to that seen in a 7-GW human embryo at the preplate stage (Fig. [2](#BHS421F2){ref-type="fig"}*E*,*F*). A definitive marker of the choroid plexus is transthyretin (Ttr; [@BHS421C70]; [@BHS421C23]), which identifies this structure in the lateral ventricles and in the third ventricle of an E12.5 mouse section (Fig. [2](#BHS421F2){ref-type="fig"}*E*). In the human brain, the entire hem system and choroid plexus express calbindin ([@BHS421C35]). From 7 to 11 GW, the human choroid plexus extensively expands, maintaining its connection with the hem, septum, and thalamic eminence (Fig. [2](#BHS421F2){ref-type="fig"}*F*--*H*). This connection is schematized in Figure [2](#BHS421F2){ref-type="fig"}*I*. The choroid plexuses of lateral and third ventricles also appear fused to each other in the human, seen in a horizontal section of a 6-GW embryo, published in [@BHS421C14]).

In prior work, we reported that Lhx2 acts to suppress cortical hem fate and is required to restrict the cortical hem to its medial location ([@BHS421C11]; [@BHS421C33]). Furthermore, the telencephalic choroid plexus, which arises from the cortical hem ([@BHS421C32]), is greatly increased in the *Lhx2* mutant mice ([@BHS421C39]). This motivated an examination of the other derivative of the cortical hem, the Cajal--Retzius cells. Furthermore, since the septum and thalamic eminence also produce Cajal--Retzius cells ([@BHS421C37]; [@BHS421C6]; [@BHS421C59]), we examined the role of Lhx2 in the development of these medial structures as well. *Lhx2* expression is seen in the septum, thalamic eminence, and hem at E11.0, but expression declines to weak or undetectable levels by E12.5 ([Supplementary Fig. S1](http://cercor.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhs421/-/DC1)).

The Septum Expands in the Absence of Lhx2 {#s3b}
-----------------------------------------

The septum functions as a rostral signaling center in the telencephalon, expressing multiple members of the Fgf family of signaling molecules and their targets ([@BHS421C24]; [@BHS421C20]; [@BHS421C19]; [@BHS421C43]). Transcription factors, *Six3* and *Zic2*, are also expressed in the septum, with *Six3* being restricted to its subpallial component ([@BHS421C44]; [@BHS421C27]; Fig. [3](#BHS421F3){ref-type="fig"}*B*,*E*). *Fgf17* expression is specific to the entire septum (Fig. [3](#BHS421F3){ref-type="fig"}*G*). *Emx1* and *Ngn2*, definitive markers of the pallial neuroepithelium, are expressed in the pallial component of the septum and the adjacent medial pallium. In the *Lhx2* mutant, expression of these genes is not seen in the medial pallium at rostral levels, suggesting a loss of pallial identity. Instead, *Zic2*, *Six3*, and *Fgf17* expression extend into the territory from which *Emx1* and *Ngn2* have receded (Fig. [3](#BHS421F3){ref-type="fig"}*A*--*F*). The expansion of *Six3*, in particular, indicates that, at rostral levels, the medial pallium has acquired an identity corresponding to the subpallial septum. We quantitated the septal area and found it to be significantly increased in the *Lhx2* mutant at E12.5 (*P* \< 0.01; Fig. [3](#BHS421F3){ref-type="fig"}*I*). Figure 3.The septum expands in the *Lhx2* mutant. (*A* and *D*) In control brains at E12.5, *Emx1* (*A*) and *Ngn2* (*D*) are expressed in the pallium (dorsal telencephalon), their expression extending medially to include the pallial septum. (*B*) *Six3* is expressed in the subpallial component of the septum and also in the subpallium (*E*). *Zic2* is expressed in both components of the septum and also adjacent medial pallial regions. In *Lhx2* mutant brains, *Emx1* and *Ngn2* expression recedes from the medial telencephalon, whereas *Zic2* and *Six3* expression expand to fill this territory (*A*, *B*, *D*, *E*), as seen in false-color overlays of adjacent sections showing *Emx1/Six3* (*C*) and *Ngn2/Zic2* (*F*) expression. *Ngn2* and *Zic2* expressions overlap in the cortical hem (*F* and *H*). Arrowheads in *A*, *B*, and *C* mark the dorsal limit of the septum and the beginning of the *Emx1*-expressing domain (*A*) in control and *Lhx2* mutant sections. (*G*) *Fgf17* is expressed in both pallial and subpallial components of control septum shown at E11.5 and E12.5. In *Lhx2* mutant, *Fgf17* expression expands dorsally (arrowhead), while its ventral limit remains normally positioned (open arrowhead). (*H*) Schematic of *Lhx2* mutant section at level "i" of Figure [1](#BHS421F1){ref-type="fig"}*F*, showing the extent of the expanded septum (s) and hem (h). (*I*) Area occupied by the septum is significantly increased in *Lhx2* mutant brains compared with that of control brains (\**P* \< 0.01). Scale bar: 300 µm.

In our previous studies, we reported of the expansion of the hem into territory that is normally occupied by the cortical neuroepithelium ([@BHS421C11]; [@BHS421C33]). This occurs throughout the telencephalon except at extreme rostral levels, where the neuroepithelium takes the identity of the septum medially and hem dorsally, as shown in Figure [3](#BHS421F3){ref-type="fig"}*H*. The hem expresses both *Zic2* and *Ngn2*, which accounts for their overlap in Figure [3](#BHS421F3){ref-type="fig"}*F*.

Cajal--Retzius Cells are Increased in the Lhx2 Mutant {#s3c}
-----------------------------------------------------

Cajal--Retzius cells are early-born neurons that arise from multiple origins and are thought to control radial migration of cortical neurons via the reelin-Dab1 signaling pathway ([@BHS421C25]; [@BHS421C57]). These cells arise from the cortical hem, septum, and thalamic eminence ([@BHS421C37]; [@BHS421C55]; [@BHS421C6]; [@BHS421C14]; Abellan and Medina [@BHS421C2]; Abellan et al. [@BHS421C9]; [@BHS421C59]; [@BHS421C35]).

In E12.5 *Lhx2* mutant forebrain, there is an overall increase in Cajal--Retzius cells as seen by expression of *Reelin*, *Lhx1, Lhx5*, and *ΔNp73*, a definitive marker of Cajal--Retzius cells arising from the forebrain hem system (Fig. [4](#BHS421F4){ref-type="fig"}*A*--*D*,*I*,*J*). Examination of labeled cells after a 2-h pulse of BrdU administered at E11.5 reveals that the labeling index in control and mutant septum (45% and 47%, respectively) and hem (46% and 45%, respectively) is similar. This indicates that cell division rates are unaffected in the absence of Lhx2. However, when BrdU injection at E11.5 is followed by BrdU/Ki67 double labeling in brains harvested 1 day later, at E12.5, the quit fraction of the mutant septum (57%) and hem (57%) is significantly increased when compared with the control septum (31%) and hem (35%; Fig. [4](#BHS421F4){ref-type="fig"}*E*--*H*,*K*--*N*). These data indicate that, in the *Lhx2* mutant septum and hem, cells exit the cell cycle prematurely, leading to an overproduction of postmitotic cells. Figure 4.Loss of Lhx2 results in an increase in Cajal--Retzius cells. (*A*--*D*) Expression of *Reelin* (*A*), *Lhx1* (*B*), *Lhx5* (*C*), and *ΔNp73* (*D*) at E12.5 reveals a considerable increase in the Cajal--Retzius cells accumulated at the septum of *Lhx2* mutants (asterisks) compared with control brains (arrowheads). (*I* and *J*) Similarly, the mantle of the mutant hem (asterisks) also shows increased Cajal--Retzius cell marker expression compared with controls (arrowheads). (*E*--*H*) corresponds to sections and cell counts for the septum and (*K*--*N*), for the hem. (*E* and *K*) Sections of E11.5 control and *Lhx2* mutant brains, after a 2-h BrdU pulse, processed for BrdU and DAPI staining. Labeling indices (BrdU^+^ cells/total DAPI^+^ cells) at E11.5 are similar for control and *Lhx2* mutant septum (45% and 47%, respectively; *E* and *G*) and hem (46% and 45%, respectively; *K* and *M*). (*F* and *L*) Sections of E12.5 *Lhx2* control and mutant brains harvested 1 day after BrdU administration at E11.5 and processed for BrdU--Ki67 double immunohistochemistry. The quit fraction (BrdU^+^; Ki67^−^ cells/total BrdU^+^ cells) is significantly greater in the *Lhx2* mutant septum (57%; \*\**P* \< 0.005) and hem (57%; \*\*\**P* \< 0.0005) than in the control septum (31%) and hem (35%). Scale bars: 300 µm (*A*--*D*); 50 µm (*E*, *F*, *K*, *L*); 100 µm (*I*, *J*).

The Thalamic Eminence Expands in the Lhx2 Mutant {#s3d}
------------------------------------------------

The thalamic eminence is seen in coronal sections as the neuroepithelium connecting the telencephalic choroid plexus to the diencephalon. Postmitotic cells of the thalamic eminence express a battery of transcription factors including *Tbr1*, *Lhx1*, *Lhx5*, and *Lhx9* ([@BHS421C13]; [@BHS421C50]; [@BHS421C49]; [@BHS421C66]; [@BHS421C3]; Fig. [5](#BHS421F5){ref-type="fig"}*A*; [Supplementary Fig. S2](http://cercor.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhs421/-/DC1)). Whereas these markers are also expressed elsewhere in the forebrain, transcription factor, *Mab21l2*, expression uniquely marks the thalamic eminence ([@BHS421C61]; [@BHS421C64]; Fig. [5](#BHS421F5){ref-type="fig"}*B*). In the absence of Lhx2, each of these markers reveals the thalamic eminence to be dramatically expanded. We compared the area of the thalamic eminence in control and *Lhx2* mutant brains and found it to be significantly greater in the absence of Lhx2 (*P* \< 0.005; Fig. [5](#BHS421F5){ref-type="fig"}*I*). Figure 5.The thalamic eminence expands in the *Lhx2* mutant. (*A* and *B*) *Tbr1* and *Mab21l2* expression in the mantle of the thalamic eminence in E12.5 control brains (arrowheads) reveal a profound expansion of this territory in the *Lhx2* mutant (white asterisk). (*A*--*D*) The *Lhx2* mutant CGE at E12.5 appears morphologically reduced and lacks *Arx* expression in its mantle (black asterisk, *C*) *a*nd *Dlx2* expression in its ventricular zone and mantle (black asterisk, *D*). (*E* and *F*) *Arx* and *Dlx2* expression appear normal in the LGE and MGE (*E* and *F*) and prethalamus (PTh; *C* and *D*). Arrowheads in control sections and white asterisks in *Lhx2* mutant sections in *A*--*D* indicate the thalamic eminence. (*G* and *J*) Sections of E11.5 control and *Lhx2* mutant brains, after a 2-h BrdU pulse, processed for BrdU and DAPI staining. Labeling indices (BrdU^+^ cells/total DAPI^+^ cells) at E11.5 are similar in the thalamic eminence of control (39%) and *Lhx2* mutant (42%) brains. (*H* and *K*) Sections of E12.5 *Lhx2* control and mutant brains harvested 1 day after BrdU administration at E11.5; and processed for BrdU--Ki67 double immunohistochemistry. The quit fraction (BrdU^+^; Ki67^−^ cells/total BrdU^+^ cells) is significantly greater in the *Lhx2* mutant thalamic eminence (62%; *P* \< 0.05) when compared with control brains (48%). (*I*) Area occupied by the thalamic eminence is significantly increased in *Lhx2* mutant brains compared with that of controls (\*\**P* \< 0.005). Scale bars: 300 µm (*A*--*F*) and 50 µm (*G* and *H*).

We examined whether the increase in the area of the thalamic eminence was at the expense of the surrounding tissue as is the case with the cortical hem and septum. These 2 structures expand at the expense of the adjacent cortical neuroepithelium (Fig. [3](#BHS421F3){ref-type="fig"}; [@BHS421C11]). Therefore, we analyzed diencephalic and telencephalic domains adjacent to the thalamic eminence in the *Lhx2* mutant. The loss of *Lhx2* does not appear to affect the position, or the extent of the prethalamus, or the thin *Lhx1/5*-expressing domain adjacent to the zona limitans intrathalamica (Fig. [5](#BHS421F5){ref-type="fig"}*C*,*D*; [Supplementary Fig. S2](http://cercor.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhs421/-/DC1)). However, in the *Lhx2* mutant, the CGE, which is normally located adjacent to the thalamic eminence, is undetectable in terms of the expression of *Dlx2* and its downstream target *Arx*. While both these genes display normal expression in the mutant lateral and medial ganglionic eminences (LGE and MGE; Fig. [5](#BHS421F5){ref-type="fig"}*E*,*F*) as well as in the prethalamus, what remains in the location of the CGE is a highly shrunken *Dlx2*- and *Arx*-negative structure (black asterisk, Fig. [5](#BHS421F5){ref-type="fig"}*A*--*D*). Thus, the expansion of the thalamic eminence is accompanied by shrinkage of the adjacent CGE, suggesting a parallel with the expansion of the cortical hem and septum.

An examination of labeling after a 2-h BrdU pulse administered at E11.5 reveals a similar labeling index in control (39%) and mutant brains (42%; Fig. [5](#BHS421F5){ref-type="fig"}*J*), indicating that cell division rates are unaffected in the absence of Lhx2. However, when BrdU injection at E11.5 is followed by BrdU/Ki67 double labeling in brains harvested 1 day later, at E12.5, the mutant thalamic eminence is seen to have a significantly increased quit fraction (62%) when compared with the control thalamic eminence (48%, Fig. [5](#BHS421F5){ref-type="fig"}*K*). This indicates that similar to the septum and hem, cells exit the cell cycle prematurely in the *Lhx2* mutant thalamic eminence as well. Interestingly, the expression of *Reelin* and *ΔNp73* ([Supplementary Fig. S3](http://cercor.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhs421/-/DC1)) is only modestly increased in the *Lhx2* mutant thalamic eminence compared with that of *Tbr1* or *Mab21l2* (Fig. [5](#BHS421F5){ref-type="fig"}*A*,*B*). Therefore, it appears that, in the absence of Lhx2, other postmitotic derivatives of the thalamic eminence are produced together with *Reelin* and *p73*-expressing Cajal--Retzius cells.

A Critical Period for Lhx2 Function in Restricting the Forebrain Hem System {#s3e}
---------------------------------------------------------------------------

*Lhx2* expression in the septum, hem, and thalamic eminence is diminished by E11.0 and undetectable by E12.5 ([Supplementary Fig. S1](http://cercor.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhs421/-/DC1)). In an earlier study, we used a conditional knockout line to demonstrate that deletion of *Lhx2* after E10.5 did not result in an expansion of the cortical hem ([@BHS421C33]). We used the same conditional knockout line crossed to *CreER* and administered tamoxifen at E10.5. We examined these conditional knockout embryos at E12.5 and find that neither the septum nor the thalamic eminence is expanded (Fig. [6](#BHS421F6){ref-type="fig"}). Therefore, the role of Lhx2 in restricting the extent of the forebrain hem system ends by E10.5, which is the stage at which the first neurons of the cortex are born, and the septum, hem, and thalamic eminence can be identified by marker gene expression in the mouse ([@BHS421C23]; [@BHS421C69]; [@BHS421C18]; [Supplementary Fig. S4](http://cercor.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhs421/-/DC1)). Figure 6.Critical period for Lhx2 to regulate the forebrain hem system ends by E10.5. Conditional deletion of *Lhx2* using a tamoxifen-inducible *CreER* driver. Tamoxifen administration at E10.5 (T10.5) does not interfere with forebrain development in control (*CreER*;*Lhx2lox/+*) embryos (*A*--*I*). A probe against *Lhx2 exon 2,3* indicates that *Lhx2* deletion has occurred throughout the brain of the floxed (*CreER;Lhx2lox/*−) embryos (*C*, *F*, *I*). (*A*--*C*) The septum in the floxed embryos appears normal as evident from *Six3* and *Fgf17* expression (bars; *A* and *B*). (*D* and *E*) Thalamic eminence expressing *Mab21l2* and *Tbr1* appear similar in the floxed embryos as that in controls (asterisk). Similarly, expression of *Wnt8b* in the cortical hem, medial pallium, and thalamic eminence as well as of *Wnt3a* in the cortical hem is comparable between floxed and control embryos (*G* and *H*). Scale bar: 300 µm.

Forebrain Hem System in Extant Vertebrates {#s3f}
------------------------------------------

The thalamic eminence and septum are thought to be evolutionarily ancient structures, having been described in fish ([@BHS421C63]; [@BHS421C62]), amphibians ([@BHS421C9], [@BHS421C10]), reptiles ([@BHS421C14]), birds ([@BHS421C48]; [@BHS421C15]), and mammals ([@BHS421C1]; [@BHS421C48]). If these indeed play a fundamental role in development, then they would be expected to be conserved in humans as well. We examined human brains at 6 and 7 GWs and made morphological comparisons of the components of the forebrain hem system between human and mouse (Fig. [7](#BHS421F7){ref-type="fig"}). The cortical hem and thalamic eminence flank the telencephalic choroid plexus in the human embryo just as they do in the mouse (Fig. [7](#BHS421F7){ref-type="fig"}*E*--*H*). In addition to calbindin, we present a comparison of 7-GW human and E12 mouse embryos using Tbr1 immunostaining, Tbr1 being expressed in the postmitotic neurons of the entire forebrain hem system in both species (Fig. [7](#BHS421F7){ref-type="fig"}*E*,*F*). A horizontal section of an E11.5 mouse brain with a morphology similar to that of the human section is shown alongside for the comparison of the location of the thalamic eminence and hem in the 2 species (Fig. [7](#BHS421F7){ref-type="fig"}*G*,*H*). The components of the forebrain hem system reported in extant vertebrates are summarized in Figure [7](#BHS421F7){ref-type="fig"}*J*. The cortical hem appears to be an evolutionarily newer structure, reported only in reptiles and mammals and being particularly prominent in the human brain ([@BHS421C23]; [@BHS421C37]; [@BHS421C14]; [@BHS421C35]). Figure 7.Presence of the forebrain hem system components in extant vertebrates. (*A*--*F*) Morphological comparisons between stage-matched mouse and human embryonic sections at rostral (*A* and *B*), middle (*C* and *D*), and caudal (*E* and *F*) levels. Tbr1 immunostaining marks the thalamic eminence in both E12 mouse and 7-GW human fetus. (*G* and *H*) A horizontal section of an E11.5 mouse brain appears morphologically comparable with a 6-GW human fetal brain section. Both species reveal the hem in the caudal telencephalon (open arrowhead) and the thalamic eminence (arrowhead) at the transition of the caudal telencephalon to the diencephalon. (*I*) Schematic of the mouse brain section in *A*, depicting the positions of the septum (yellow), cortical hem (red), and thalamic eminence (blue). (*J*) Tabulation of the presence of the 3 medial sources of Cajal--Retzius cells in the developing forebrain of different vertebrates ([@BHS421C23]; [@BHS421C1]; [@BHS421C48]; [@BHS421C15]; [@BHS421C9], [@BHS421C10]; [@BHS421C37]; [@BHS421C63]; [@BHS421C62]; [@BHS421C14]).

Discussion {#s4}
==========

In this study, we examine 3 structures located at important morphological boundaries in the medial forebrain, septum, hem, and thalamic eminence and find that they are unified by significant common features. It was already known that these boundary structures express specific complements of signaling molecules (Fgfs, Wnts, and Bmps) ([@BHS421C21]; [@BHS421C23]; [@BHS421C24]; [@BHS421C30]). These structures were also previously known or proposed to play major roles in forebrain patterning events, and to produce Cajal--Retzius cells, which are implicated in aspects of patterning and cell migration in the forebrain ([@BHS421C37]; [@BHS421C55]; [@BHS421C6]; [@BHS421C67]; [@BHS421C14]; [@BHS421C2]; [@BHS421C9]; [@BHS421C59]; [@BHS421C35]). We discovered a key feature that unifies these structures, namely that transcription factor Lhx2 acts to limit their extent. We observe all 3 structures to expand in the *Lhx2* mutant. The major patterning disruptions occur in the *Lhx2* mutant involving the expansion of the septum, hem, and thalamic eminence into adjacent territories ([@BHS421C11]; [@BHS421C33]; this study). This expansion appears to be due to a fate change of the adjacent neuroepithelium: The rostral cortex in the case of the septum; the mid level cortex in the case of the hem; and the CGE in the case of the thalamic eminence. These expanded neuroepithelial domains also display an enhanced quit fraction, resulting in a great excess of postmitotic cells produced from the septum, hem, and thalamic eminence. We propose that these structures function as a multicomponent medial organizing system, the forebrain hem system, which regulates the development of the forebrain.

Our forebrain hem system model builds upon and extends the idea of the cortical hem and the septum as medial organizers in the telencephalon. It is well established that the Wnt-rich cortical hem acts as an organizer for the adjacent cortical neuroepithelium to become hippocampus. In mosaic embryos consisting of *Lhx2* null and wild-type cells, multiple hems are formed within the cortical neuroepithelium, and ectopic hippocampi are induced adjacent to each hem ([@BHS421C33]). *Fgf8*, expressed in the septum, is critical in regulating cortical arealization. An ectopic source of Fgf8 in the caudal telencephalon is sufficient to produce a mirror-image duplication of the cortical area map ([@BHS421C20]). The thalamic eminence is known to secrete a composite set of signaling molecules ([@BHS421C30]) and is suggested to be a putative signaling centre at the DTB ([@BHS421C1]; [@BHS421C29]). The thalamic eminence is also the site through which the thalamocortical axons cross the diencephalon to enter the telencephalon. In the *Lhx2* mutant, the thalamic eminence expands at the expense of the CGE, which is an important source of interneurons for the caudal cerebral cortex and hippocampus ([@BHS421C41]; [@BHS421C68]). We suggest that this structure may function as a diencephalic hem, to regulate key aspects of forebrain patterning and development.

Our new perspective unifies 3 key forebrain midline structures and may provide a way of understanding holoprosencephaly, the most common congenital malformation of the human forebrain with a prevalence of 1 in 250 conceptions and 1 in 16 000 live births ([@BHS421C44]; [@BHS421C8]; [@BHS421C60]; [@BHS421C4]; [@BHS421C45]; [@BHS421C52]). Key genes that are implicated in holoprosencephaly are transcription factors *Zic2, Six3*, and signaling molecules *Fgf8* and Bmps, which are expressed in part or all of the forebrain hem system, and Shh, which is expressed in adjacent ventral regions. *Six3*, expressed in the subpallial septum and other ventral structures, is a major locus affected in human holoprosencephaly ([@BHS421C44]; [@BHS421C60]). Shh is a critical ventral signaling molecule and its absence results in holoprosencephaly with malformation/reduction of only ventral midline structures; in contrast, the *Bmpr1a/b* double mutant displays dorsal holoprosencephaly (midline interhemispheric holoprosencephaly), including a severe reduction of the hem, absence of the choroid plexus, and partial fusion of the hemispheres ([@BHS421C17]). The absence of *Zic2* results in both dorsal and ventral midline defects ([@BHS421C8]). Zic2 levels appear to regulate fundamental morphogenetic events such as the timing of neurulation and roof plate formation ([@BHS421C40]). Mechanistically, Zic2 is thought to act in part via the regulation of β-catenin activity, which is a major downstream mediator of Wnt signaling ([@BHS421C47]). Our results show that *Zic2* is expressed in the entire forebrain hem system and provides a new framework in which phenotypes associated with its deficiency can be interpreted. Broadly, the defects associated with holoprosencephaly are due to deficiencies in the specification of, or signaling from key midline structures. In contrast, the absence of Lhx2 results in an \*expansion\* of the same midline structures. We propose that our interpretation of the forebrain hem system as an entity may lead to different approaches to analyzing holoprosencephalies.

Our findings position Lhx2 in a fundamental role in regulating forebrain development by controlling the formation of this organizer system, acting not only to delimit its extent, but also to maintain its neuroepithelial stem cells in a proliferative mode. In [@BHS421C33], we examined mosaic embryos that contained *Lhx2* mutant and wild-type patches of neuroepithelium and showed that the expansion of the hem is due to a cell autonomous role of Lhx2. We expect a similar cell-autonomous function for Lhx2 in both the septum and thalamic eminence as well, with a critical period that ends at E10.5 by which time these structures are identifiable (Fig. [6](#BHS421F6){ref-type="fig"}). Supporting this interpretation, *Lhx2* expression in the forebrain hem system drops significantly by this stage, consistent with a scenario in which Lhx2 must be downregulated in order for the structures to gain their identity.

An interesting feature of the hem and septum is that they appear to cross-regulate each other, after they are formed. This regulation is mutually repressive in which BMPs from the hem curtail the extent of the septum, and Fgf8 from the septum curtails the extent of the *Wnt* expression domain, that is, the hem ([@BHS421C51]). But since the role of Lhx2 is complete by E10.5, it is unlikely that these cross-repressive interactions might mediate the function of Lhx2. Rather, they appear to act to maintain internal boundaries within the forebrain hem system. How Lhx2 suppresses a range of alternative fates to preserve the extent of the cortex, or the forebrain at large is a compelling question for future studies.

An important property of the forebrain hem system is that all its components are sources of the Cajal--Retzius cells which, in turn, are the main source of Reelin signal in the developing telencephalon. Each component of the forebrain hem system is also connected to the choroid plexus, and at least one component, the hem, is thought to produce the choroid plexus as well ([@BHS421C32]). A mechanistic link between Cajal--Retzius cells and the choroid plexus has been discovered in the mouse, in which *Ngn2* and *Hes* genes antagonistically regulate the specification of these 2 fates, respectively ([@BHS421C26]). Both have critical roles in cortical development: Cajal--Retzius cells being sources of Reelin ([@BHS421C16]; [@BHS421C42]) and choroid plexus being the source of the cerebrospinal fluid, which contains a complex cocktail of proteins that nourishes the brain ([@BHS421C56]; [@BHS421C34]). The forebrain hem system is therefore positioned to regulate the development of the telencephalon, and potentially also its expansion in evolution. As summarized in Figure [7](#BHS421F7){ref-type="fig"}*J*, components of this system have been identified in several vertebrate species. Both the septum and thalamic eminence have been identified in all vertebrate phyla including fish (Fig. [7](#BHS421F7){ref-type="fig"}*J*) and may represent the beginnings of the evolution of a comprehensive medial organizing cluster, the forebrain hem system. The hem appears to have arisen most recently in evolution, possibly in the common ancestor of reptiles and mammals, since it has been reported in both phyla. The hem may be particularly important for human brain development since it provides the Cajal--Retzius cells for the greatly expanded neocortex; furthermore, the organizing activities of the forebrain hem system may culminate in determining the extent of the human neocortex.
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